As of 25 Oct 2026, Beta Drugs Ltd share price is ₹1,894.60. The stock opened at ₹1,894.60 and had closed at ₹1,971.00 the previous day. Over the last 52 weeks, the stock has recorded a low of ₹990.10 and a high of ₹2,807.90. In terms of performance, Beta Drugs Ltd share price has increased by 45.48% over the past six months and has increased by 3.22% over the last year.
BETA Stock Price Chart
Beta Drugs Ltd Overview
About BETA
Beta Drugs is an India-based pharmaceutical company specializing in the development, manufacturing, and marketing of anti-cancer (oncology) medications and formulations
Beta Drugs Ltd Historical Performance
Beta Drugs Ltd Fundamentals
Beta Drugs Ltd Financials
| Indicator | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| Revenue | 236.57 | 226.39 | 199.35 | 158.91 | 125.71 |
| EBITDA | 39.69 | 33.04 | 35.25 | 32.24 | 26.04 |
| Net Profit | 14.33 | 15.43 | 21.94 | 18.82 | 14.25 |
| EPS | 14.14 | 15.29 | 22.82 | 19.57 | 14.82 |
Beta Drugs Ltd Technical Analysis
| Indicator | Value |
|---|---|
| Support 1 (S1) | 1,725.47 |
| Resistance 1 (R1) | 2,107.07 |
| Pivot Point | 1,861.53 |
BETA Key Leadership Details
Last Updated: Mar 2025
| Name | Position |
|---|---|
| Rahul Batra | Chairman & Managing Director |
| Varun Batra | Managing Director |
| Balwant Singh | Whole-time Directorector |
Beta Drugs Ltd Peer Comparison
| Company | Price | M.Cap (Cr) | P/E (TTM) | ROE (TTM) |
|---|---|---|---|---|
| Sun Pharmaceutical Industries LtdSUNPHARMA | ₹1,748.00-0.57% | ₹4,19,727.66 | 38.32 | 13.74% |
| Divis Laboratories LtdDIVISLAB | ₹8,950.00-2.31% | ₹1,67,235.91 | 67.46 | 15.32% |
| Torrent Pharmaceuticals LtdTORNTPHARM | ₹4,524.40-1.97% | ₹1,46,951.32 | 64.68 | 11.42% |
Disclaimer
The information provided on this page is for informational purposes only and should not be construed as investment advice, recommendation, or solicitation to buy or sell any securities or financial pr...
Frequently Asked Questions
- The share price of Beta Drugs Ltd today is ₹1,894.60 on NSE and ₹1,894.60 on BSE.
- The 52-week high of Beta Drugs Ltd is ₹2,807.90, while the 52-week low is ₹990.10.
- The current market capitalisation of Beta Drugs Ltd is approximately ₹2,100 crore.
- The P/E (Price-to-Earnings) ratio of Beta Drugs Ltd is 25.76. The ratio may vary with changes in the share price and earnings.
- The P/B (Price-to-Book) ratio of Beta Drugs Ltd is 4.68. It compares the company’s market value with its book value and can provide an indication of how the market values the company relative to its net assets.
- To buy Beta Drugs Ltd shares, you first need to open a demat account before you can place an order. Here's the process:
• Open a demat account online using your PAN, Aadhaar and bank details.
• Add funds to your trading account via UPI or net banking.
• Search for BETA on TradeMobi or the Anand Rathi web platform.
• Place your order
• Track your holdings in the portfolio section. - Over the past 3 years, Beta Drugs Ltd has delivered a return of approximately 120.50%. This return is based on the change in the share price over the specified period and may differ depending on the measurement date. Past performance does not guarantee future returns.
- The shareholding pattern of Beta Drugs Ltd comprises different categories of shareholders. As of Jun 2026, the shareholding is approximately 59.10% promoters, 1.02% FIIs, 6.23% DIIs, and 24.30% public shareholders.
Download TradeMobi App
- Real-Time Market Data
- Advanced Trading Tools
- Expert-Backed Research
